Victory Capital Management Inc Vaccinex, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.28 - $4.24 $6,760 - $8,738	-2,061 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$3.96 - $8.37 $5,346 - $11,299	1,350 Added 189.87%	2,061 $8,000
Q4 2019 Feb 04, 2020	BUY	$4.56 - $7.45 $1,650 - $2,696	362 Added 103.72%	711 $5,000
Q3 2019 Nov 12, 2019	BUY	$4.02 - $7.93 $1,402 - $2,767	349 New	349 $3,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $287M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.